Back
SPDR S&P Global Dividend ETF Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Sell
42
WDIV
SPDR S&P Global Dividend ETF
Last Price:
$75.68
Seasonality Move:
0.82%
Buy
57
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$536.81
Seasonality Move:
15.11%
Sell
42
SPDR S&P Global Dividend ETF (WDIV)
is a Sell
Is SPDR S&P Global Dividend ETF a Buy, Sell or Hold?
-
The current SPDR S&P Global Dividend ETF [WDIV] share price is $75.29. The Score for WDIV is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
WDIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $546.19. The Score for MDGL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WDIV Stock Price Chart
What is SPDR S&P Global Dividend ETF's stock price today?
-
The SPDR S&P Global Dividend ETF share price today is $75.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WDIV is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $546.19The current trend is moderately bearish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
WDIV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.01 | Buy |
| Relative Strength Index (14 RSI): | 60.01 | Buy |
| Chaikin Money Flow: | -3637 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.88 - 75.26) | Buy |
| Bollinger Bands (100): | (72.03 - 74.33) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.12 | Buy |
| Relative Strength Index (14 RSI): | 49.65 | Sell |
| Chaikin Money Flow: | -199987 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (541.81 - 584.93) | Sell |
| Bollinger Bands (100): | (377.57 - 529.47) | Buy |
WDIV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.08 | Buy |
| 20-day SMA: | 74.6 | Buy |
| 50-day SMA: | 73.8 | Buy |
| 200-day SMA: | 70.47 | Buy |
| 8-day EMA: | 16.73 | Buy |
| 20-day EMA: | 7.17 | Buy |
| 50-day EMA: | 2.95 | Buy |
| 200-day EMA: | 0.75 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 559.88 | Sell |
| 20-day SMA: | 569.93 | Sell |
| 50-day SMA: | 503.41 | Buy |
| 200-day SMA: | 380.65 | Buy |
| 8-day EMA: | 560.16 | Sell |
| 20-day EMA: | 555.94 | Sell |
| 50-day EMA: | 516.55 | Buy |
| 200-day EMA: | 408.33 | Buy |
SPDR S&P Global Dividend ETF Earnings Growth & WDIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.31 per share, and an increase next year of $15.02 per share.
SPDR S&P Global Dividend ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||